Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
Anavex Life Sciences (AVXL) Confirms Information in July 27 Press Release Announcing Positive Results from Phase 2a Alzheimer's Trial for ANAVEX 2-73
July 29, 2016 9:22 AM EDTAnavex Life Sciences Corp. (Anavex or the Company) (Nasdaq: AVXL), confirms the information in the July 27, 2016 press release announcing positive results from the Phase 2a Alzheimers trial for ANAVEX 2-73.
Dr. Norman Relkin, MD, PhD, an Alzheimer clinical trialist and an advisor to Anavex, commented: To interpret the ANAVEX 2-73 results presented at the 2016 AAIC meeting, it is important to keep in mind the stated goals of this... More
FBR Capital Recommends Buying Anavex Life Sciences (AVXL) After Yesterday's Weakness
July 28, 2016 7:45 AM EDTFBR Capital analyst Christopher James reiterated his Outperform rating and $10 price target on Anavex Life Sciences (NASDAQ: AVXL) following yesterday's weakness following efficacy data in AD.
James commented, "On July 27, Anavex Life Sciences presented additional data from its ongoing Part-B extension of the Phase IIa study with Anavex 2-73 (AV2-73) in... More
Anavex Life Sciences (AVXL) Continues Plunge Following Data
July 27, 2016 1:56 PM EDTAnavex Life Sciences (NASDAQ: AVXL) continues lower following data. Shares are now down 40% after being halted several times.
... MoreAnavex Life Sciences (AVXL) Halted on LUDP
July 27, 2016 1:21 PM EDTAnavex Life Sciences (NASDAQ: AVXL) Halted on LUDP
... MoreAnavex Life Sciences (AVXL) Resumes Trading; Shares Down 25%
July 27, 2016 1:14 PM EDTAnavex Life Sciences (NASDAQ: AVXL) resumes again from second LUDP halt following data. Shares last down 25%.
... MoreAnavex Life Sciences (AVXL) Halted Again on LUDP
July 27, 2016 1:07 PM EDTAnavex Life Sciences (NASDAQ: AVXL) Halted Again on LUDP
... MoreAnavex Life Sciences (AVXL) triggers limit-up, limit-down trading pause
July 27, 2016 1:02 PM EDTAnavex Life Sciences (NASDAQ: AVXL) triggers limit-up, limit-down trading pause.
... More